MedTrace Logo

Prehospital Norepinephrine and Early Mortality in Traumatic Shock

NCT04497155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2164

Last updated 2022-02-10

No results posted yet for this study

Summary

The effect of early, prehospital norepinephrine use in patients with traumatic shock on mortality is unknown. Recent existing observational evidence from single system data (US, France, Japan) are conflicting. The investigators hypothesize that prehospital norepinephrine is associated with decreased mortality when used in patients with traumatic shock.

Conditions

Interventions

DRUG

Norepinephrine

Trauma patients with prehospital or arrival to the trauma center hypotension, defined as a systolic blood pressure \<100 mmHg, that received norepinephrine during prehospital transport or in the resuscitation unit.

Sponsors & Collaborators

  • Beaujon Hospital

    collaborator OTHER

  • University Grenoble Alps

    collaborator OTHER

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Tobias Gauss, MD · Hospital Beujon

  • Pierre Bouzat, MD, PhD · University Grenoble Alps

  • Justin E Richards, MD · R Adams Cowley Shock Trauma Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2018-12-31
Completion
2021-12-31
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04497155 on ClinicalTrials.gov